首页|2 型糖尿病患者血清hsa-miR-30c-5p水平表达对微血管并发症的预测价值研究

2 型糖尿病患者血清hsa-miR-30c-5p水平表达对微血管并发症的预测价值研究

扫码查看
目的 探讨2型糖尿病(type 2 diabetes mellitus,T2DM)患者血清人微小核糖核酸(homo sapiens microRNA,hsa-miR)-30c-5p表达对微血管并发症的预测价值.方法 选取2021年5月~2022年9月巴中市中心医院收治的T2DM患者205例为糖尿病组,并根据患者微血管并发症情况将糖尿病组进一步分为并发组(n=124)和未并发组(n=81),另选取同期健康体检者205例为对照组,均采用逆转录-聚合酶链反应(reverse transcription-polymerase chain reaction,RT-PCR)检测受试者血清hsa-miR-30c-5p表达并进行比较.采用多因素Logistic回归分析影响微血管并发症的因素,绘制受试者工作特征(receiver operating characteristic,ROC)曲线预测血清hsa-miR-30c-5p表达对T2DM患者发生微血管并发症的价值.结果 并发组、未并发组的血清hsa-miR-30c-5p表达分别为0.58±0.06,0.72±0.08,均低于对照组(0.89±0.21),差异具有统计学意义(t=16.038,7.079,均P=0.001);并发组低于未并发组,差异具有统计学意义(t=14.289,P=0.001).糖尿病病程[OR(95%CI):3.873(2.976~4.770)]、尿酸[OR(95%CI):2.125(1.211~3.040)]、糖化血红蛋白[OR(95%CI):2.680(1.745~3.616)]均为 T2DM 患者发生微血管并发症的独立危险因素(均P<0.05),葡萄糖目标范围内时间[OR(95%CI):0.491(0.135~0.846)]、血清 hsa-miR-30c-5p[OR(95%CI):0.532(0.146~0.817)]均为 T2DM 患者发生微血管并发症的保护因素(均 P<0.05).血清hsa-miR-30c-5p表达预测T2DM患者发生微血管并发症的敏感度、特异度、曲线下面积(95%置信区间)分别为 81.45%,85.19%,0.802(0.741~0.854).结论 T2DM 患者血清 hsa-miR-30c-5p 表达异常降低,且血清 hsa-miR-30c-5p为T2DM患者发生微血管并发症的保护因素,对T2DM患者发生微血管并发症具有一定的预测价值.
Study on the Predictive Value of Serum Hsa-miR-30c-5p Level Expression in Patients with Type 2 Diabetes Mellitus for Micro vascular Complications
Objective To explore the predictive value of serum homo sapiens microRNA(hsa-miR)-30c-5p expression in patients with type 2 diabetes mellitus(T2DM)for microvascular complications.Methods A total of 205 T2DM patients admitted to Bazhong Central Hospital from May 2021 to September 2022 were selected as the diabetes group,and the diabetes group was further divided into diabetes with combined group(n=124)and non combined group(n=81)according to the microvascular complications of the patients.In addition,205 healthy people who underwent physical examination during the same period were selected as the control group.The expression of hsa-miR-30c-5p in serum was detected by reverse transcription-polymerase chain reaction(RT-PCR)and compared.The factors affecting microvascular complications were analyzed using multivariate logistic regression analysis,and receiver operating characteristic(ROC)curves were plotted to predict the value of serum hsa-miR-30c-5p expression in predicting microvascular complications in T2DM patients.Results The expression of serum hsa-miR-30c-5p in the combined group(0.58±0.06)and the non-combined group(0.72±0.08)were lower than that in the control group(0.89±0.21),and the differences were significant(t=16.038,7.079,all P=0.001).The combined group was lower than the non-combined group,and the difference was significant(t=14.289,P=0.001).The course of diabetes[(OR(95%CI):3.873(2.976~4.770)],uric acid[(OR(95%CI):2.125(1.211~3.040)]and glycosylated hemoglobin[(OR(95%CI):2.680(1.745~3.616)]were independent risk factors for microvascular complications in T2DM patients(all P<0.05),while the time within the target range of glucose[(OR(95%CI):0.491(0.135~0.846)]and serum hsa-miR-30c-5p[(OR(95%CI):0.532(2.976~4.770)]were protective factors for microvascular complications in T2DM patients(all P<0.05).The sensitivity,specificity and area under the curve(95%CI)of serum hsa-mir-30c-5p expression in predicting microvascular complications in T2DM patients were 81.45%,85.19%and 0.802(0.741~0.854),respectively.Conclusion The expression of serum hsa-miR-30c-5p in patients with T2DM is abnormally reduced,and serum hsa-miR-30c-5p is a protective factor for microvascular complications in patients with T2DM.It may have a certain predictive value for microvascular complications in patients with T2DM.

type 2 diabetes mellitusmicrovascular complicationshomo sapiens microRNA-30c-5p

熊小芹、冯潇宇、毛爱珺、马丁、石亚军

展开 >

巴中市中心医院内分泌科,四川巴中 636000

巴中市中心医院感染科,四川巴中 636000

2型糖尿病 微血管并发症 人微小核糖核酸-30c-5p

2024

现代检验医学杂志
陕西省临床检验中心,陕西省人民医院

现代检验医学杂志

CSTPCD
影响因子:0.713
ISSN:1671-7414
年,卷(期):2024.39(5)